RU2007110813A - Пищевая композиция, включающая иммуноглобулины и олигосахариды - Google Patents
Пищевая композиция, включающая иммуноглобулины и олигосахариды Download PDFInfo
- Publication number
- RU2007110813A RU2007110813A RU2007110813/15A RU2007110813A RU2007110813A RU 2007110813 A RU2007110813 A RU 2007110813A RU 2007110813/15 A RU2007110813/15 A RU 2007110813/15A RU 2007110813 A RU2007110813 A RU 2007110813A RU 2007110813 A RU2007110813 A RU 2007110813A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- immunoglobulin
- galactose
- infection
- activity against
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract 24
- 108060003951 Immunoglobulin Proteins 0.000 title claims abstract 11
- 102000018358 immunoglobulin Human genes 0.000 title claims abstract 11
- 229920001542 oligosaccharide Polymers 0.000 title claims abstract 5
- 150000002482 oligosaccharides Chemical class 0.000 title claims abstract 5
- 229940072221 immunoglobulins Drugs 0.000 title 1
- 229930182830 galactose Natural products 0.000 claims abstract 6
- 208000015181 infectious disease Diseases 0.000 claims abstract 5
- 238000000034 method Methods 0.000 claims abstract 5
- 230000002265 prevention Effects 0.000 claims abstract 5
- 241000124008 Mammalia Species 0.000 claims abstract 2
- 210000003022 colostrum Anatomy 0.000 claims abstract 2
- 235000021277 colostrum Nutrition 0.000 claims abstract 2
- 235000013336 milk Nutrition 0.000 claims abstract 2
- 210000004080 milk Anatomy 0.000 claims abstract 2
- 239000008267 milk Substances 0.000 claims abstract 2
- 150000001720 carbohydrates Chemical group 0.000 claims 8
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 3
- 230000003472 neutralizing effect Effects 0.000 claims 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims 2
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 229920001202 Inulin Polymers 0.000 claims 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims 2
- 241000702670 Rotavirus Species 0.000 claims 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims 2
- 229940029339 inulin Drugs 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 244000000010 microbial pathogen Species 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- 208000005577 Gastroenteritis Diseases 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 241000725643 Respiratory syncytial virus Species 0.000 claims 1
- 206010057190 Respiratory tract infections Diseases 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 150000002256 galaktoses Chemical class 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 235000013311 vegetables Nutrition 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Pediatric Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (17)
1. Применение a) галоктозосодержащего неперевариваемого олигосахарида, содержащего, по меньшей мере, два концевых сахаридных фрагмента, где, по меньшей мере, один концевой сахаридный фрагмент выбран из группы, включающей глюкозу и галактозу; и, по меньшей мере, один концевой сахарид выбран из группы, включающей галактозу и фукозу; и b) иммуноглобулин, обладающий активностью против патогенных микроорганизмов,
для изготовления композиции для лечения и/или предотвращения инфекции.
2. Применение по п.1, где композицию вводят младенцу.
3. Применение по любому из п.1 или 2, где композицию вводят перорально.
4. Применение по любому из п.1 или 2, где иммуноглобулин вводят в количестве от 0,05 г на кг массы тела до 2 г на кг массы тела в день.
5. Применение по любому из п.1 или 2, где композиция применяется в способе лечения и/или предотвращения инфекции дыхательных путей.
6. Применение по любому из п.1 или 2, где композиция применяется в способе лечения и/или предотвращения гастроэнтерита.
7. Применение по любому из п.1 или 2, где композиция применяется в способе лечения и/или предотвращения заболевания, связанного с первичной инфекцией дыхательных путей или кишечника.
8. Композиция, пригодная для лечения и/или предотвращения инфекции или заболевания и включающая a) галоктозосодержащий неперевариваемый олигосахарид, содержащий, по меньшей мере, два концевых сахаридных фрагмента, где, по меньшей мере, один концевой сахаридный фрагмент выбран из группы, состоящей из глюкозы и галактозы; и, по меньшей мере, один концевой сахарид выбран из группы, состоящей из галактозы и фукозы; и b) иммуноглобулин, обладающий активностью против патогенных микроорганизмов.
9. Композиция по п.8, включающая волокнистый углевод, жир и/или белок растительного, животного (не человеческого), бактериального или синтетического происхождения.
10. Композиция по п.8 или 9, где иммуноглобулин получен или может быть получен из молока или молозива гипериммунизированных млекопитающих.
11. Композиция по любому из п.8 или 9, включающая иммуноглобулин, обладающий нейтрализующей активностью в отношении респираторно-синцитиального вируса.
12. Композиция по любому из п.8 или 9, включающая иммуноглобулин, обладающий нейтрализующей активностью в отношении ротавируса.
13. Композиция по любому из п.8 или 9, где композиция включает от 0,25 до 5 мас.% иммуноглобулина из расчета на сухую массу композиции.
14. Композиция по любому из п.8 или 9, включающая от 10 до 60% (эн.) липида, от 5 до 50% (эн.) белка и от 15 до 90% (эн.) углевода, где эн.% представляет относительное количество, которое каждый комплект вносит в общее значение композиции.
15. Композиция по любому из п.8 или 9, дополнительно включающая неперевариваемый олигосахарид, выбранный из группы, состоящей из фруктоолигосахаридов, гидролизованного инулина и инулина.
16. Композиция по п.14, где иммуноглобулин включает иммуноглобулин, обладающей нейтрализующей активностью в отношении ротавируса.
17. Применение композиции по любому из пп.8-16 для изготовления композиции для лечения и/или предотвращения инфекции.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04077394.7A EP1629850B2 (en) | 2004-08-24 | 2004-08-24 | Nutritional composition comprising indigestible transgalactooligosaccharides and digestible galactose saccharides |
| EP04077394.7 | 2004-08-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2007110813A true RU2007110813A (ru) | 2008-10-10 |
| RU2385714C2 RU2385714C2 (ru) | 2010-04-10 |
Family
ID=34928473
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007110822/15A RU2385725C2 (ru) | 2004-08-24 | 2005-08-24 | Пищевая композиция, содержащая неперевариваемые олигосахариды |
| RU2007110813/15A RU2385714C2 (ru) | 2004-08-24 | 2005-08-24 | Пищевая композиция, включающая иммуноглобулины и олигосахариды |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007110822/15A RU2385725C2 (ru) | 2004-08-24 | 2005-08-24 | Пищевая композиция, содержащая неперевариваемые олигосахариды |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US8277835B2 (ru) |
| EP (5) | EP1629850B2 (ru) |
| JP (1) | JP5142717B2 (ru) |
| CN (2) | CN101043904B (ru) |
| AT (1) | ATE361101T1 (ru) |
| AU (2) | AU2005275576B2 (ru) |
| BR (1) | BRPI0514536A (ru) |
| CA (2) | CA2577926C (ru) |
| DE (1) | DE602004006258T3 (ru) |
| DK (2) | DK1629850T4 (ru) |
| ES (3) | ES2286558T5 (ru) |
| NZ (1) | NZ553390A (ru) |
| PL (2) | PL1629850T5 (ru) |
| PT (2) | PT1629850E (ru) |
| RU (2) | RU2385725C2 (ru) |
| SG (1) | SG170119A1 (ru) |
| TR (1) | TR201820868T4 (ru) |
| UA (1) | UA89791C2 (ru) |
| WO (2) | WO2006022542A1 (ru) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2591831C2 (ru) * | 2009-07-15 | 2016-07-20 | Н.В. Нютрисиа | Смесь неусваиваемых олигосахаридов для стимулирования иммунной системы |
| RU2773674C2 (ru) * | 2009-07-15 | 2022-06-07 | Н.В. Нютрисиа | Смесь неусваиваемых олигосахаридов для стимулирования иммунной системы |
Families Citing this family (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006012536A2 (en) | 2004-07-22 | 2006-02-02 | Ritter Andrew J | Methods and compositions for treating lactose intolerance |
| ATE361101T1 (de) | 2004-08-24 | 2007-05-15 | Nutricia Nv | Nahrungszusammensetzung die unverdauliche oligosaccharide enthält |
| US20060229366A1 (en) * | 2005-04-07 | 2006-10-12 | Lifschitz Carlos H | Method for preventing or treating respiratory infections in infants |
| EP1714660A1 (en) * | 2005-04-21 | 2006-10-25 | N.V. Nutricia | Uronic acid and probiotics |
| EP1776877A1 (en) | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
| US20070202215A1 (en) * | 2006-02-28 | 2007-08-30 | Zahramehran Salari Lak | Dietary nutritional supplements for persons consuming alcohol products |
| WO2007101675A1 (en) * | 2006-03-07 | 2007-09-13 | Nestec S.A. | Synbiotic mixture |
| WO2008054193A1 (en) * | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Nutritional products that comprise saccharide oligomers |
| NL1032840C2 (nl) * | 2006-11-09 | 2008-05-13 | Friesland Brands Bv | Probiotische hydrolysaatvoeding voor kinderen. |
| WO2008153377A1 (en) * | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
| CA2743334A1 (en) * | 2007-11-12 | 2009-05-22 | Samsara Medicin Ab | Methods relating to breathing disorders |
| US20110223248A1 (en) * | 2007-12-12 | 2011-09-15 | Ritter Pharmaceuticals, Inc. | Methods and compositions for treating lactose intolerance |
| BRPI0909289A2 (pt) * | 2008-03-14 | 2015-08-04 | Nestec Sa | Mistura simbiótica |
| EP2130440A1 (en) * | 2008-06-06 | 2009-12-09 | N.V. Nutricia | Inhibiting E. sakazakii growth |
| WO2009157759A1 (en) * | 2008-06-23 | 2009-12-30 | N.V. Nutricia | Nutritional composition for improving the mammalian immune system |
| WO2010002241A1 (en) * | 2008-06-30 | 2010-01-07 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
| US20100043075A1 (en) * | 2008-08-13 | 2010-02-18 | Autodesk, Inc. | Licensing management utility |
| WO2010068086A1 (en) * | 2008-12-11 | 2010-06-17 | N.V. Nutricia | Nutritional compositions with large lipid globule size |
| SG2014014435A (en) | 2009-02-24 | 2014-07-30 | Ritter Pharmaceuticals Inc | Prebiotic formulations and methods of use |
| ES2559008T3 (es) * | 2009-05-11 | 2016-02-10 | Nestec S.A. | Bifidobacterium longum NCC2705 no replicante y trastornos inmunitarios |
| EP4197542A1 (en) * | 2009-07-15 | 2023-06-21 | N.V. Nutricia | Fucosyllactose as breast milk identical non-digestible oligosaccharide for use in enhancing vaccination response |
| EP2322169A1 (en) * | 2009-11-13 | 2011-05-18 | Laboratorios Casen-Fleet, S.L. | Composition containing a DHA oil for use in the treatment of cystic fibrosis |
| NL2004099C2 (en) * | 2010-01-15 | 2011-07-18 | Friesland Brands Bv | Milk derived antigen specific antibodies for inducing an adaptive immune response, methods of preparation and uses thereof. |
| BE1019290A5 (nl) | 2010-04-14 | 2012-05-08 | Nutrition Sciences Nv Sa | Voedingsupplement omvattende oligosachariden en middellange keten vetzuren. |
| WO2011137249A1 (en) | 2010-04-28 | 2011-11-03 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| MY164281A (en) | 2010-11-23 | 2017-11-30 | Pantheryx Inc | Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications |
| EP2465509A1 (en) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharide composition for treating acute respiratory tract infections |
| WO2012087113A1 (en) * | 2010-12-24 | 2012-06-28 | N.V. Nutricia | Improved nutritional tablet |
| WO2012092153A1 (en) | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection |
| WO2012092157A2 (en) | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof |
| ES2667393T3 (es) * | 2010-12-31 | 2018-05-10 | Abbott Laboratories | Oligosacáridos de leche humana para modular inflamación |
| NZ613180A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods of using human milk oligosaccharides for improving airway respiratory health |
| JP5900792B2 (ja) * | 2011-02-21 | 2016-04-06 | 国立大学法人信州大学 | フェルラ酸結合型糖質の製造方法 |
| US8563611B2 (en) * | 2011-03-17 | 2013-10-22 | Women's & Children's Health Research Institute | Methods and compositions for promoting the respiratory development of an infant |
| RU2464796C1 (ru) * | 2011-06-01 | 2012-10-27 | Государственное образовательное учреждение высшего профессионального образования Воронежская государственная технологическая академия (ГОУ ВПО ВГТА) | Способ получения фукозосодержащей функциональной добавки из молочной сыворотки |
| US10039296B2 (en) | 2011-06-20 | 2018-08-07 | H.J. Heinz Company Brands Llc | Probiotic compositions and methods |
| WO2012177118A1 (en) * | 2011-06-22 | 2012-12-27 | N.V. Nutricia | Method for reducing the occurrence of infection in young children |
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| NL2007268C2 (en) | 2011-08-16 | 2013-02-19 | Friesland Brands Bv | Nutritional compositions comprising human milk oligosaccharides and uses thereof. |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| RU2471496C1 (ru) * | 2011-11-17 | 2013-01-10 | Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии Сибирского отделения РАМН | Средства, повышающие противоопухолевую и антиметастатическую активность цитостатических препаратов |
| MY187609A (en) | 2012-12-18 | 2021-10-04 | Abbott Lab | Human milk oligosaccharides to ameliorate symptoms of stress |
| ITMI20122270A1 (it) | 2012-12-31 | 2014-07-01 | Giovanni Mogna | Terapia di supporto ai trattamenti di chemioterapia per i tumori, per la sindrome da immunodeficienza acquisita e per le leucemie. |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| PL2994150T3 (pl) | 2013-05-10 | 2019-09-30 | H.J. Heinz Company Brands Llc | Probiotyki i sposoby zastosowania |
| SE537951C2 (sv) * | 2013-07-01 | 2015-12-01 | Hero Ag | Profylaktisk användning av modersmjölksersättning mot otit |
| EP3111942B1 (en) | 2013-11-15 | 2021-01-06 | Société des Produits Nestlé S.A. | Compositions for use in the prevention or treatment of urt infections in infants or young children at risk |
| JPWO2016042831A1 (ja) * | 2014-09-18 | 2017-04-27 | 協和化学工業株式会社 | 大腸の検査または手術のための処置用製剤 |
| EP3400953A1 (en) | 2014-12-23 | 2018-11-14 | 4D Pharma Research Limited | Pirin polypeptide and immune modulation |
| KR102523805B1 (ko) | 2014-12-23 | 2023-04-20 | 4디 파마 리서치 리미티드 | 면역 조정 |
| DK3206700T3 (da) | 2015-06-15 | 2019-08-05 | 4D Pharma Res Ltd | Sammensætninger omfattende bakteriestammer |
| PT3307288T (pt) | 2015-06-15 | 2019-10-17 | 4D Pharma Res Ltd | Composições compreendendo estirpes bacterianas |
| MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| PT3240554T (pt) | 2015-06-15 | 2019-11-04 | 4D Pharma Res Ltd | Blautia stercosis e wexlerae para uso no tratamento de doenças inflamatórias e autoimunes |
| MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| CN107921058B (zh) * | 2015-08-04 | 2021-04-16 | 南方糖业股份公司 | 菊糖对鼻窦炎的预防作用 |
| KR101914245B1 (ko) | 2015-11-20 | 2018-11-02 | 4디 파마 리서치 리미티드 | 박테리아성 균주를 함유한 조성물 |
| GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| MX2018007124A (es) | 2015-12-15 | 2018-09-07 | Nestec Sa | Mezcla de hmo. |
| EP3397075A1 (en) * | 2015-12-29 | 2018-11-07 | N.V. Nutricia | Nutritional formula with non-digestible oligosaccharides and non-replicating lactic acid producing bacteria |
| EP3207933A1 (en) * | 2016-02-17 | 2017-08-23 | Proponent Biotech GmbH | Uses of polyfructans |
| MA42560B1 (fr) | 2016-03-04 | 2019-07-31 | 4D Pharma Plc | Compositions comprenant des souches bactériennes de blautia pour le traitement de l'hypersensibilité viscérale |
| GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
| TW201821093A (zh) | 2016-07-13 | 2018-06-16 | 英商４Ｄ製藥有限公司 | 包含細菌菌株之組合物 |
| GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
| TW201907928A (zh) | 2017-05-22 | 2019-03-01 | 英商4D製藥研究有限公司 | 包含細菌品系之組成物 |
| MA41708A (fr) | 2017-05-24 | 2020-04-08 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| ES2841902T3 (es) | 2017-06-14 | 2021-07-12 | 4D Pharma Res Ltd | Composiciones que comprenden cepas bacterianas |
| MA49425A (fr) | 2017-06-14 | 2020-04-22 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| WO2019031961A1 (en) | 2017-08-11 | 2019-02-14 | N.V. Nutricia | OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION |
| WO2019246316A1 (en) * | 2018-06-19 | 2019-12-26 | Evolve Biosystems, Inc. | Novel oligosaccharides for use in prebiotic applications |
| CN108888762A (zh) * | 2018-08-15 | 2018-11-27 | 福建傲农生物科技集团股份有限公司 | 一种含益生菌代谢产物的组合物 |
| EP4003061B1 (en) * | 2019-07-23 | 2024-04-24 | FrieslandCampina Nederland B.V. | Nutritional composition comprising milk fat and immunoglobulin |
| EP4132560A1 (en) * | 2020-04-06 | 2023-02-15 | Abbott Laboratories | Nutritional formulations for modulating respiratory-induced cytokines |
| WO2021222660A1 (en) * | 2020-04-30 | 2021-11-04 | Kaleido Biosciences, Inc. | Oligosaccharide compositions and methods of use thereof for treating viral infections |
| AU2021273198A1 (en) * | 2020-05-13 | 2023-02-02 | Glycosyn LLC | Fucosylated oligosaccharides for prevention of coronavirus infection |
| US11324766B2 (en) | 2020-05-13 | 2022-05-10 | Glycosyn LLC | 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation |
| EP4370104A1 (en) * | 2021-07-16 | 2024-05-22 | Purdue Research Foundation | Prebiotic composition and method of use to improve gastrointestinal health in patients with dysbiosis and leaky gut |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH627079A5 (en) | 1977-04-15 | 1981-12-31 | Nestle Sa | Process for preparing a protein concentrate containing immunological factors of milk origin |
| SE8301609D0 (sv) | 1983-03-23 | 1983-03-23 | Svenska Sockerfabriks Ab | Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling |
| US4661345A (en) | 1985-02-26 | 1987-04-28 | The Rockefeller University | Method for treating pertussis |
| NZ222902A (en) | 1986-12-15 | 1990-08-28 | Yakult Honsha Kk | Method for producing galactooligosaccharide |
| US4800078A (en) * | 1987-05-28 | 1989-01-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb |
| SE462134B (sv) | 1987-10-22 | 1990-05-14 | Biocarb Ab | Livsmedel innehaallande lacto-n-tetraos och foerfarande foer dess framstaellning |
| ES2127198T3 (es) | 1990-08-02 | 1999-04-16 | Antex Biolog Inc | Receptores de adhesion para microorganismos patogenos u oportunistas. |
| US5902617A (en) * | 1992-05-19 | 1999-05-11 | Pabst; Patrea L. | Enzyme supplemented baby formula |
| US5531989A (en) | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Immunoglobulin and fiber-containing composition for human gastrointestinal health |
| US5922344A (en) | 1995-02-10 | 1999-07-13 | Abbott Laboratories | Product for prevention of respiratory virus infection and method of use |
| US5736533A (en) | 1995-06-07 | 1998-04-07 | Neose Technologies, Inc. | Bacterial inhibition with an oligosaccharide compound |
| EP1254664A3 (en) | 1995-07-10 | 2004-01-02 | Abbott Laboratories | Enteral products containing indigestible oligosaccharides for treating and preventing otitis media in humans |
| ES2123903T5 (es) | 1995-08-04 | 2011-02-22 | N.V. Nutricia | Composición nutritiva conteniendo fibra. |
| CN1191828C (zh) | 1997-03-27 | 2005-03-09 | 布里斯托尔-迈尔斯斯奎布公司 | 二十二碳六烯酸和花生四烯酸促进不足月婴儿生长的用途 |
| US6045854A (en) | 1997-03-31 | 2000-04-04 | Abbott Laboraties | Nutritional formulations containing oligosaccharides |
| US5906982A (en) | 1997-03-31 | 1999-05-25 | Abbott Laboratories | Nutritional formulations containing Lacto-N-neoTetraose |
| US6145670A (en) * | 1997-09-22 | 2000-11-14 | Risser; William | Bathtub spout with removable filter |
| DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
| EP0951842B1 (en) | 1999-01-20 | 2002-12-04 | N.V. Nutricia | Infant formula |
| EP1062873A1 (en) * | 1999-12-13 | 2000-12-27 | N.V. Nutricia | Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate |
| DE10006989A1 (de) | 2000-02-16 | 2001-08-23 | Nutricia Nv | Antiadhäsive Kohlenhydratmischung |
| FR2809312B1 (fr) * | 2000-05-25 | 2002-07-12 | Gervais Danone Sa | Utilisation de l. casei dans des compositions immunostimulantes |
| AU5596600A (en) * | 2000-06-07 | 2001-12-17 | Bridge Pharma Inc | Treating smooth muscle hyperactivity with (r)-oxybutynin and (r)- desethyloxybutynin |
| WO2001097817A1 (en) | 2000-06-21 | 2001-12-27 | James Zhou Liu | Health promoting foods |
| GB0016045D0 (en) | 2000-06-29 | 2000-08-23 | Laxdale Limited | Therapeutic combinations of fatty acids |
| DE10057976B4 (de) | 2000-11-22 | 2005-02-03 | Südzucker AG Mannheim/Ochsenfurt | Verfahren zur Herstellung von Pektinhydrolyseprodukten |
| JP2004520318A (ja) | 2000-12-27 | 2004-07-08 | エヌ・ヴイ・ヌートリシア | オリゴ糖を含有する健康増進作用を有する栄養組成物 |
| FI109602B (fi) * | 2001-01-25 | 2002-09-13 | Valio Oy | Probioottiyhdistelmä |
| DE10147100A1 (de) | 2001-09-25 | 2003-04-17 | Numico Res B V | Antiinfektive Kohlenhydrate |
| AU2002325026A1 (en) | 2001-09-27 | 2003-04-07 | St. Jude Children's Research Hospital, Inc. | Use of neuraminidase inhibitors to prevent flu associated bacterial infections |
| DE60301677T2 (de) | 2002-02-04 | 2006-07-06 | Kyowa Hakko Kogyo Co., Ltd. | Pharmazeutische und Lebenmittelzusammensetzungen mit einem Di- oder Oligosaccharid, das die Insulinfreisetzung steigert |
| DE60327211D1 (de) | 2002-06-28 | 2009-05-28 | Glykos Finland Oy | Therapeutische zusammensetzungen zur verwendung bei der prophylaxe oder behandlung von durchfall |
| GB0229015D0 (en) | 2002-12-12 | 2003-01-15 | Novartis Nutrition Ag | New Compound |
| US7862808B2 (en) | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
| EP1634599A1 (en) | 2004-08-20 | 2006-03-15 | N.V. Nutricia | Iimmune stimulatory infant nutrition |
| ATE361101T1 (de) | 2004-08-24 | 2007-05-15 | Nutricia Nv | Nahrungszusammensetzung die unverdauliche oligosaccharide enthält |
| NZ613180A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods of using human milk oligosaccharides for improving airway respiratory health |
-
2004
- 2004-08-24 AT AT04077394T patent/ATE361101T1/de active
- 2004-08-24 DK DK04077394.7T patent/DK1629850T4/da active
- 2004-08-24 EP EP04077394.7A patent/EP1629850B2/en active Active
- 2004-08-24 DE DE602004006258T patent/DE602004006258T3/de active Active
- 2004-08-24 PL PL04077394T patent/PL1629850T5/pl unknown
- 2004-08-24 PT PT04077394T patent/PT1629850E/pt unknown
- 2004-08-24 ES ES04077394T patent/ES2286558T5/es active Active
-
2005
- 2005-08-24 BR BRPI0514536-8A patent/BRPI0514536A/pt not_active Application Discontinuation
- 2005-08-24 RU RU2007110822/15A patent/RU2385725C2/ru active
- 2005-08-24 RU RU2007110813/15A patent/RU2385714C2/ru not_active IP Right Cessation
- 2005-08-24 UA UAA200701942A patent/UA89791C2/ru unknown
- 2005-08-24 CA CA2577926A patent/CA2577926C/en not_active Expired - Fee Related
- 2005-08-24 JP JP2007529745A patent/JP5142717B2/ja active Active
- 2005-08-24 DK DK10180272.6T patent/DK2359858T3/da active
- 2005-08-24 EP EP05775176A patent/EP1784218A1/en not_active Ceased
- 2005-08-24 EP EP10180272.6A patent/EP2359858B1/en not_active Revoked
- 2005-08-24 CA CA2576562A patent/CA2576562C/en active Active
- 2005-08-24 NZ NZ553390A patent/NZ553390A/xx unknown
- 2005-08-24 ES ES05775158T patent/ES2704599T3/es active Active
- 2005-08-24 EP EP14173107.5A patent/EP2851090A1/en not_active Withdrawn
- 2005-08-24 PT PT101802726T patent/PT2359858T/pt unknown
- 2005-08-24 WO PCT/NL2005/000611 patent/WO2006022542A1/en active Application Filing
- 2005-08-24 US US11/574,123 patent/US8277835B2/en active Active
- 2005-08-24 WO PCT/NL2005/000612 patent/WO2006022543A1/en active Application Filing
- 2005-08-24 TR TR2018/20868T patent/TR201820868T4/tr unknown
- 2005-08-24 ES ES10180272T patent/ES2929515T3/es active Active
- 2005-08-24 SG SG201101844-7A patent/SG170119A1/en unknown
- 2005-08-24 US US11/574,180 patent/US9566291B2/en active Active
- 2005-08-24 AU AU2005275576A patent/AU2005275576B2/en active Active
- 2005-08-24 CN CN2005800358190A patent/CN101043904B/zh active Active
- 2005-08-24 EP EP05775158.8A patent/EP1784222B1/en not_active Revoked
- 2005-08-24 AU AU2005275577A patent/AU2005275577B2/en not_active Ceased
- 2005-08-24 CN CN2005800355239A patent/CN101094687B/zh not_active Expired - Fee Related
- 2005-08-24 PL PL10180272.6T patent/PL2359858T3/pl unknown
-
2012
- 2012-09-14 US US13/620,216 patent/US20130102560A1/en not_active Abandoned
-
2014
- 2014-03-05 US US14/198,421 patent/US20140296179A1/en not_active Abandoned
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2591831C2 (ru) * | 2009-07-15 | 2016-07-20 | Н.В. Нютрисиа | Смесь неусваиваемых олигосахаридов для стимулирования иммунной системы |
| RU2773674C2 (ru) * | 2009-07-15 | 2022-06-07 | Н.В. Нютрисиа | Смесь неусваиваемых олигосахаридов для стимулирования иммунной системы |
| RU2794127C2 (ru) * | 2009-07-15 | 2023-04-11 | Н.В. Нютрисиа | Смесь неусваиваемых олигосахаридов для стимулирования иммунной системы |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2007110813A (ru) | Пищевая композиция, включающая иммуноглобулины и олигосахариды | |
| AU709155B2 (en) | Compositions and methods for human gastrointestinal health | |
| RU2018107583A (ru) | Питательные композиции с 2fl и lnnt для применения при индукции кишечной микробиоты, которая похожа на кишечную микробиоту младенцев на грудном вскармливании | |
| WO1997020577A1 (en) | Improved therapeutic formulation and method | |
| RU2008136419A (ru) | Смесь олигосахаридов | |
| Clausen | The influence of nutrition upon resistance to infection | |
| JP2006149371A (ja) | 乳清タンパク食品 | |
| EP0706400A1 (en) | Therapeutic formulation and method | |
| EA199700448A1 (ru) | Способ лечения злокачественных опухолей или лечения и/или профилактики и/или инфекции заболевания желудочно-кишечного тракта и/или диареи, композиция для перорального введения, способ получения гранул или подобных твердых композиций, пища для человека или корм для животных или птиц | |
| CN106578134A (zh) | 一种预防感染性腹泻的婴儿配方奶粉 | |
| Jang et al. | Role of milk carbohydrates in intestinal health of nursery pigs: a review | |
| UA78699C2 (en) | Use of bile acid or bile salt fatty acid conjugates for decreasing cholesterol blood content, treating fatty liver, hyperglycemia, and diabetes | |
| Farnworth | Fructans in human and animal diets | |
| Porter et al. | Significance of immune mechanisms in relation to enteric infections of the gastrointestinal tract in animals | |
| US7045149B2 (en) | Ruminal fluid inoculation of calves | |
| Reiter et al. | The antibacterial activity of lactoferrin and neonatal E. coli infections: a selective and critical review | |
| Ul Haq et al. | Prebiotics: the gut ecology modifiers | |
| JP7231163B2 (ja) | 糖及び／又は脂質の代謝改善剤 | |
| Saha et al. | Use of human colostrum in the management of chronic infantile diarrhoea due to enteropathogenic E. coli infection with associated intestinal parasite infestations and undernutrition | |
| Alimirzaei et al. | Prolonged Colostrum Feeding to Improve Calf Growth and Health: A Promising Practice? | |
| RU2646831C1 (ru) | Лекарственная композиция и способ ее применения для профилактики и терапии диспепсических состояний новорожденных телят, полученных от инфицированных лейкозом коров | |
| AU5957799A (en) | Compositions and methods for human gastrointestinal health | |
| US20170014443A1 (en) | Compositions and methods for treating gastrointestinal disorders for humans and animal husbandry | |
| Tzipori | Piglet Enteritis; Field and Laboratory Evaluation of Enteropathogens Associated with 3 Disease Entities | |
| WO2024003223A1 (en) | Fucosylated saccharide for use in the prevention or treatment of parasitic disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20200825 |